|1.||Sorsa, Timo: 32 articles (02/2016 - 01/2002)|
|2.||Sorsa, T: 21 articles (02/2015 - 05/2000)|
|3.||Tervahartiala, Taina: 19 articles (02/2016 - 02/2007)|
|4.||Yoon, Bo Hyun: 13 articles (01/2015 - 01/2002)|
|5.||Romero, Roberto: 11 articles (05/2014 - 01/2002)|
|6.||Tervahartiala, T: 7 articles (02/2015 - 09/2005)|
|7.||Park, Chan-Wook: 7 articles (01/2015 - 10/2004)|
|8.||Salo, Tuula: 7 articles (10/2014 - 11/2002)|
|9.||Mäntylä, Päivi: 6 articles (02/2016 - 08/2003)|
|10.||Jun, Jong Kwan: 6 articles (01/2015 - 10/2004)|
01/01/2011 - "The aim of the study was to evaluate the efficacy of Parodontax® (GlaxoSmith-Kline, Bühl, Germany) on the signs gingival inflammation and the enzyme activity of matrix metalloproteinase-8 (aMMP-8) in the gingival crevicular fluid. "
01/01/2013 - "The aim of this study was to evaluate the signs of gingival inflammation and the enzyme activity of matrix metalloproteinase-8 (aMMP-8) in the gingival crevicular fluid of pregnant women. "
10/01/2004 - "Matrix metalloproteinase-8 was used because previous studies indicated that this was a sensitive and specific index of inflammation and that is correlated with the amniotic fluid white blood cell count. "
05/01/2010 - "Intraamniotic inflammation was defined as an elevated amniotic fluid (AF) matrix metalloproteinase-8 concentration (>23 ng/mL). "
01/01/2010 - "Intra-amniotic inflammation was defined as an elevated AF matrix metalloproteinase-8 (MMP-8) concentration (>23 ng/mL). "
02/01/2012 - "Genetic and pharmacologic inhibition of matrix metalloproteinase-8 leads to improved survival and a blunted inflammatory profile in a murine model of sepsis. "
02/01/2015 - "Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy."
01/01/2014 - "Matrix metalloproteinase-8 inhibitors mitigate sepsis-induced myocardial injury in rats."
02/01/2012 - "A murine model of sepsis was used to explore the effect of genetic and pharmacologic inhibition of matrix metalloproteinase-8 on the inflammatory response to sepsis. "
02/01/2012 - "We further corroborate the role of matrix metalloproteinase-8 in sepsis in a murine model. "
11/01/2003 - "We generated mice deficient in collagenase-2 (Mmp8), an MMP mainly produced by neutrophils in inflammatory reactions and detected in some malignant tumors. "
11/01/2003 - "Loss of collagenase-2 confers increased skin tumor susceptibility to male mice."
01/01/1985 - "Matrix influence on the tumor cell stimulation of fibroblast collagenase production."
01/01/2011 - "To investigate the effect of intratumoral administration of collagenase-2 on liposomal drug accumulation and diffusion in solid tumor xenografts. "
01/01/2015 - "Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice."
|4.||Tongue Neoplasms (Tongue Neoplasm)
01/01/2014 - "Inhibition of neutrophil collagenase/MMP-8 and gelatinase B/MMP-9 and protection against endotoxin shock."
08/15/2005 - "Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock."
01/01/2014 - "Endotoxin shock is a life-threatening disorder, associated with the rapid release of neutrophil enzymes, including neutrophil collagenase/matrix metalloproteinase-8 (MMP-8) and gelatinase B/matrix metalloproteinase-9 (MMP-9). "
|1.||Matrix Metalloproteinase 9 (Gelatinase B)
|4.||Matrix Metalloproteinase 8 (Neutrophil Collagenase)
|5.||Tissue Inhibitor of Metalloproteinase-1
|6.||Leukocyte Elastase (Neutrophil Elastase)
|8.||Matrix Metalloproteinase 1 (Interstitial Collagenase)
|10.||Interleukin-6 (Interleukin 6)
|1.||Heterologous Transplantation (Xenotransplantation)
|3.||Hormone Replacement Therapy (Therapy, Hormone Replacement)
|5.||Oral Hygiene (Dental Hygiene)